Masanori Tokumoto
Overview
Explore the profile of Masanori Tokumoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujimoto T, Inoue S, Matsunaga T, Shimizu T, Mitsubuchi H, Matsuyoshi T, et al.
Cancer Diagn Progn
. 2024 May;
4(3):295-300.
PMID: 38707737
Background/aim: Surgical outcomes of colorectal cancer (CRC) in patients with renal failure (RF) remain to be clarified. The objective of this research was to investigate how RF impacts the surgical...
2.
Haruyama N, Nakayama M, Yamada S, Tanaka S, Hiyamuta H, Taniguchi M, et al.
J Bone Miner Metab
. 2024 Mar;
42(2):253-263.
PMID: 38509305
Introduction: In patients undergoing dialysis, major bone fracture is associated with a high risk of mortality, including death of cardiovascular (CV) origin. In the present study, we aimed to determine...
3.
Inaguma D, Koiwa F, Tokumoto M, Fukagawa M, Yoneda S, Yasuzawa H, et al.
Clin Kidney J
. 2023 Dec;
16(12):2614-2625.
PMID: 38045997
Background: Upacicalcet is a novel small-molecule calcimimetic agent developed for intravenous injection. Here, we evaluated the long-term efficacy and safety of upacicalcet treatment via intraindividual dose adjustment in haemodialysis patients...
4.
Inoue M, Nakai K, Tanaka S, Mitsuiki K, Tokumoto M, Tsuruya K, et al.
Clin Exp Nephrol
. 2023 Aug;
27(12):1023-1031.
PMID: 37642786
Background: Hyponatremia is a common and important electrolyte disorder. However, the prevalence and factors associated with hyponatremia in patients with chronic kidney disease (CKD) are unknown. Methods: We studied the...
5.
Shukuri T, Nakai K, Tanaka S, Yamada S, Tokumoto M, Tsuruya K, et al.
Clin Exp Nephrol
. 2023 Jul;
27(11):919-927.
PMID: 37498346
Background: Angiotensin II receptor blockers (ARBs) reportedly reduce the risk of developing bone fractures; however, this association remains unclear among patients with chronic kidney disease (CKD). Methods: This was a...
6.
Nakano T, Kishimoto H, Tokumoto M
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1059179.
PMID: 36909314
Fibroblast growth factor (FGF)23 is a bone-derived phosphotropic hormone that regulates phosphate and mineral homeostasis. Recent studies have provided evidence that a high plasma concentration of FGF23 is associated with...
7.
Kishimoto H, Nakano T, Torisu K, Tokumoto M, Uchida Y, Yamada S, et al.
Front Cardiovasc Med
. 2023 Mar;
10:990422.
PMID: 36895836
Background: Patients with chronic kidney disease (CKD) have a high risk of left ventricular hypertrophy (LVH). Fibroblast growth factor 23 (FGF23) and indoxyl sulfate (IS) are associated with LVH in...
8.
Tokumoto M, Tokunaga S, Asada S, Endo Y, Kurita N, Fukagawa M, et al.
PLoS One
. 2022 Dec;
17(12):e0279078.
PMID: 36512619
The dosage of evocalcet required to control serum parathyroid hormone (PTH) levels varies among secondary hyperparathyroidism (SHPT) patients. This post hoc analysis evaluated the dose-dependent efficacy of evocalcet on serum...
9.
Yamada S, Tanaka S, Arase H, Hiyamuta H, Kitamura H, Tokumoto M, et al.
Clin Exp Nephrol
. 2022 Nov;
27(2):151-160.
PMID: 36318395
Background: Constipation is a common complication in patients with chronic kidney disease (CKD) and is involved in the pathogenesis of dysbiosis and progression of CKD. However, little is known about...
10.
Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, et al.
Kidney Med
. 2022 Apr;
4(3):100408.
PMID: 35386605
Rationale & Objective: Malnutrition-inflammation complex syndrome (MICS) is common in patients receiving hemodialysis and increases the risks of morbidity and mortality. However, few studies have examined the overall impact of...